|
PEX19 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.598000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.482200E-01 |
| Normal-vs-Stage2 |
5.464200E-01 |
| Normal-vs-Stage3 |
8.850400E-01 |
| Normal-vs-Stage4 |
9.409600E-01 |
| Stage1-vs-Stage2 |
6.524400E-01 |
| Stage1-vs-Stage3 |
6.200200E-01 |
| Stage1-vs-Stage4 |
8.695600E-01 |
| Stage2-vs-Stage3 |
4.462000E-01 |
| Stage2-vs-Stage4 |
6.298000E-01 |
| Stage3-vs-Stage4 |
8.430200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.444200E-01 |
| Normal-vs-AfricanAmerican |
2.955100E-03 |
| Normal-vs-Asian |
8.660600E-01 |
| Caucasian-vs-AfricanAmerican |
2.516800E-03 |
| Caucasian-vs-Asian |
7.965600E-01 |
| AfricanAmerican-vs-Asian |
2.722400E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.155200E-01 |
| Normal-vs-Female |
5.334400E-01 |
| Male-vs-Female |
1.861550E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.994800E-01 |
| Normal-vs-Age(41-60Yrs) |
7.239800E-01 |
| Normal-vs-Age(61-80Yrs) |
7.887000E-01 |
| Normal-vs-Age(81-100Yrs) |
2.773000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.615800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.296400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.987400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.612600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.053600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.106600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.866500E-02 |
| Classical-VS-Follicular |
7.100400E-01 |
| Classical-VS-Other |
2.016600E-01 |
| Classical-VS-Normal |
4.105800E-01 |
| Tall-VS-Follicular |
2.968800E-01 |
| Tall-VS-Other |
5.083800E-01 |
| Tall-VS-Normal |
3.916600E-01 |
| Follicular-VS-Other |
3.763600E-01 |
| Follicular-VS-Normal |
7.823400E-01 |
| Other-VS-Normal |
2.480400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.028000E-01 |
| Normal-vs-N1 |
1.842240E-01 |
| N0-vs-N1 |
9.441500E-02 |
|
|
